Annual general meeting 2024
Kosmopol, København K
- Invitation
- Conduct, chairman’s report and signed minutes
- All available presentations as one zip file
- – Kaspar Rufibach’s presentation
Annual general meeting 2023
Kosmopol, København K
- Invitation
- Conduct, chairman’s report and signed minutes
- Addendum to meeting minutes (post-meeting notes)
- All available presentations as one zip file
Annual general meeting 2022 and 30-year anniversary
Nordisk Film, Valby
- Invitation
- Conduct, chairman’s report and signed minutes
- All available presentations as one zip file
Annual general meeting 2021
Held as on-line meeting due to the COVID-19 pandemic
- Invitation
- Conduct, chairman’s report and signed minutes
- Presentation by Jens Nielsen, SSI (substitute for Palle Valentiner-Branth)
Annual general meeting 2020
Held as on-line meeting due to the COVID-19 pandemic
Annual general meeting 2019
Annual general meeting 2018
Annual general meeting 2017 (25th Anniversary)
Presentations from DSBS 25th Anniversary – 31 March 2017
| Speaker | Presentation as pdf |
|---|---|
| Agenda | Detailed program |
| Karsten Schmidt, Claus Bay & Merete Jørgensen | Biostatistics in the regulatory environment and the formation of DSBS in the 1990’s |
| Ralf Bender, Institute for Quality and Efficiency in Health Care (IQWiG) | Evaluation of subgroup analyses in the framework of benefit assessment |
| Erik Doffagne, CluePoints | Using central statistical monitoring to drive quality into clinical trials |
| Nedjad Losic, Genmab | Two Bayesian designs for first-in-human trials in cancer |
| Anders Malmberg, Ferring | A phase II trial with response-adaptive allocation |
| Lasse Sluth, Lundbeck and Lars Endahl, Novo Nordisk | Regulatory interaction with Asia |
Annual general meeting 2016
Annual general meeting 2015
Annual general meeting and presentations 2014
- Invitation
- Minutes
- Sharing Clinical Trial Reports and Data Access – Some practicalities (Merete Jørgensen)
Annual general meeting and presentations 2013
- Invitation
- Minutes
- Missing data in Clinical Trials (Søren Andersen)
- Efficacy Data in Regulatory Settings (Henrik Loft)
Annual general meeting and presentations 2012
Annual general meeting and presentations 2011
- Invitation
- Minutes
- The extended Williams� trend test – Background and practical example (Anders Malmberg)
- Exposure-Response Analysis � Regulatory perspectives (Christoffer W. Tornøe)
Annual general meeting and presentations 2010
- Invitation
- Minutes
- Discussion on Randomisation and Blinding (Lars Endahl)
- Perspectives on Non-Inferiority Clinical Trials � based on draft FDA guidance doc (Kristian Windfeld)
Annual general meeting 2009
Annual general meeting 2008
Annual general meeting and presentations 2007
Annual general meeting and Miniseminar on Data Monitoring Commitees and safety 2006
- Invitation
- Information about the seminar on Data Monitoring Commitees and safety
- Integrated Analyses of Safety – Data needed! (Marie Louise Valentin)
- DMC � how and what should they evaluate? (Bjarne Nielsen)
- Analysis of Safety Data – Is More Enough? (Marc Andersen)
Annual general meeting and seminar on QT prolongation 2005
- Invitation
- Minutes
- Information about seminar on QT prolongation
- Introduction to QT Prolongation Trials (Thomas Jon Jensen)
- Status on guidelines (Bjarne Nielsen)